Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Identifying potential tumor markers and antigens by database mining and rapid expression screening.

Loging WT, Lal A, Siu IM, Loney TL, Wikstrand CJ, Marra MA, Prange C, Bigner DD, Strausberg RL, Riggins GJ.

Genome Res. 2000 Sep;10(9):1393-402.

2.

Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells.

Parsels LA, Parsels JD, Wagner LM, Loney TL, Radany EH, Maybaum J.

Cancer Chemother Pharmacol. 1998;42(5):357-62.

3.

Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype.

Parsels LA, Zellars RC, Loney TL, Parsels JD, Clarke MF, Merchant AK, Lawrence TS, Maybaum J.

Mol Pharmacol. 1997 Oct;52(4):600-5.

PMID:
9380022
4.

Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells.

Merchant AK, Loney TL, Maybaum J.

Oncogene. 1996 Dec 19;13(12):2631-7.

PMID:
9000137
5.

Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation.

Lawrence TS, Davis MA, Loney TL.

Cancer Res. 1996 Jul 15;56(14):3203-6.

Supplemental Content

Loading ...
Support Center